Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls

Biological Psychiatry
N OzakiD Goldman

Abstract

We screened the 5-HT2A receptor gene coding region in 50 patients with seasonal affective disorder (SAD) using a single strand conformational polymorphism analysis and estimated the frequencies of two synonymous and two non-synonymous substitutions we detected in 70 Centre d'Etude du Polymorphism Humain (CEPH) population controls and 62 normal controls. Both of the amino acid substitutions: Ala447-Val447 and His452-Tyr452, were located within the cytoplasmic. C-terminal tail of the receptor. Rarer allele frequencies in CEPH were 0.7% and 9.3% for Val447 and Tyr452, respectively. Allele frequencies of all four polymorphisms, including the two amino acid substitutions, were not significantly different in SAD patients as compared to CEPH and normal controls. Lack of association of Val447 and Tyr452 to SAD is consistent with observations showing normal 5-HT2A receptor Ca2+ response in platelets with this disorder, however, the two 5-HT2A amino acid substitutions may lead to differences in behavioral phenotypes.

References

Jun 1, 1992·Brain Research. Molecular Brain Research·K ChenJ C Shih
Dec 31, 1991·Biochemical and Biophysical Research Communications·A G SaltzmanS Felder
Jan 1, 1991·Annual Review of Neuroscience·D Julius
May 11, 1989·Nucleic Acids Research·A HaliassosA Kitzis
Mar 1, 1989·Archives of General Psychiatry·P A McBrideJ J Mann
Jun 1, 1988·Archives of General Psychiatry·E R RitvoR S Sparkes
Jan 1, 1985·Behavior Genetics·M A SpenceB J Freeman

❮ Previous
Next ❯

Citations

Jun 10, 2009·Human Genetics·Ian R GizerIrwin D Waldman
Feb 18, 2004·Thrombosis Research·Masakatsu ShimizuMitsuhiro Yokoyama
Jan 3, 2001·European Journal of Pharmacology·J Veenstra-VanderWeeleE H Cook
Jul 11, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·C FehrN Dahmen
Jan 26, 2006·European Journal of Human Genetics : EJHG·Nicola FilippiniMassimo Gennarelli
May 20, 2003·Neurotoxicity Research·Bárbara AriasLourdes Fañanás
Feb 3, 1999·Annals of the New York Academy of Sciences·M GöthertM M Nöthen
Nov 5, 1998·Lancet·T Partonen, J Lönnqvist
Jul 15, 1999·Journal of Affective Disorders·L SherN E Rosenthal
Jan 1, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Concepcion Vaquero-LorenzoMaria A Oquendo
May 11, 2012·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Fayaz SeifuddinPeter P Zandi
Aug 19, 2008·Annales pharmaceutiques françaises·Y Le StratP Gorwood
Aug 21, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ayman H FanousKenneth S Kendler
Jan 8, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Giuseppe BlasiAlessandro Bertolino
Aug 19, 2007·The International Journal of Neuropsychopharmacology·Misuzu TanakaKazunori Mine
Dec 19, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Charles E GlattNelson B Freimer
Feb 3, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ayman H FanousK S Kendler
Nov 12, 2003·The Pharmacogenomics Journal·Y YamanouchiN Ozaki
Oct 21, 2003·Nature Neuroscience·Dominique J-F de QuervainAndreas Papassotiropoulos
Oct 16, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R D LevitanJ L Kennedy
Apr 25, 2006·Journal of Clinical Psychopharmacology·Hsien-Yuan LaneWen-Ho Chang
Sep 8, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ana Paula M GuimarãesMara H Hutz
Dec 16, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Cristian Patrick ZeniLuis Augusto Rohde
Jan 24, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·V E GolimbetT V Lezheiko
May 2, 2003·Chronobiology International·Andres Magnusson, Diane Boivin
Jul 26, 2005·CNS Spectrums·Chang-Ho Sohn, Raymond W Lam
Aug 13, 2020·Eating and Weight Disorders : EWD·Sirine Abou Al HassanLama Mattar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.